24 unchanged sentences
Recent Sales of Unregistered Securities
−Removed: On November 1, 2022, we acquired a 75% controlling interest in Heart and Lung Imaging Limited in part by issuing 359,002 shares at $19.06 per share with a fair value of $6.8 million.
−Removed: The shares of common stock were issued to the four holders of the outstanding equity of Heart and Lung Imaging Limited.
−Removed: The shares were issued without registration on the basis of the exemption for private placement transactions provided by Section 4(a)(2) of the Securities Act.
+Added: On December 12, 2023, we issued 64,569 shares of common stock to settle a milestone contingent liability as part of our purchase of Heart & Lung Imaging Limited.
+Added: The shares were ascribed a value of $2.3 million.
+Added: On September 20, 2023, we issued 56,600 shares of common stock to settle a milestone contingent liability as part of our purchase of Heart & Lung Imaging Limited.
+Added: The shares were ascribed a value of $1.6 million.
+Added: On July 7, 2023, we issued 113,303 shares of common stock to settle the stock portion of a holdback contingent liability as part of our purchase of Quantib B.V.
+Added: The shares were ascribed a value of $3.5 million.
+Added: On April 30, 2023, we issued 114,227 shares of common stock to settle a holdback contingent liability as part of our purchase of Aidence Holding B.V.
+Added: The shares were ascribed a value of $4.0 million.
+Added: In each of the foregoing transactions, the shares of common stock issued without registration on the basis of the exemption for private placement transactions provided by Section 4(a)(2) of the Securities Act.
Not Required.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.